# Avalo Therapeutics Inc. (AVTX) — Gross Profit

## Annual Gross Profit (USD)

| Year | Gross Profit |
| --- | --- |
| 2023 | $640,000 |
| 2022 | $15M |
| 2021 | $4M |
| 2020 | $6M |
| 2019 | $7M |
| 2018 | $4M |
| 2017 | $27M |
| 2016 | $1M |
| 2015 | — |

## Quarterly Gross Profit (USD)

| Quarter | Gross Profit |
| --- | --- |
| 2024-09-30 | $963,000 |
| 2024-06-30 | -$343,000 |
| 2024-03-31 | $80,000 |
| 2023-09-30 | -$11,000 |
| 2023-06-30 | -$65,000 |
| 2023-03-31 | -$76,000 |
| 2022-09-30 | $14M |
| 2022-06-30 | -$534,000 |
| 2022-03-31 | $453,000 |
| 2021-09-30 | $442,000 |
| 2021-06-30 | $3M |
| 2021-03-31 | $396,000 |
| 2020-09-30 | $1M |
| 2020-06-30 | $1M |
| 2020-03-31 | $3M |
| 2019-09-30 | $2M |
| 2019-06-30 | $3M |
| 2019-03-31 | $2M |
| 2018-09-30 | $963,496 |
| 2018-06-30 | $3M |
| 2018-03-31 | $4M |
| 2017-09-30 | $25M |
| 2017-06-30 | $157,800 |
| 2017-03-31 | $384 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/AVTX/gross-profit)